Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Recent Review on Cancer Nanomedicine
Paras Mani Giri, Anurag Banerjee, Buddhadev Layek
Cancers (2023) Vol. 15, Iss. 8, pp. 2256-2256
Open Access | Times Cited: 65

Showing 26-50 of 65 citing articles:

Lipid-based nanomedicine for colorectal cancer: Progress and prospects
Fereshteh Asgharzadeh, Maryam Moradi Binabaj, Sahar Fanoudi, et al.
Alexandria Engineering Journal (2025) Vol. 122, pp. 385-398
Closed Access
Clotrimazole a new frontier: Drug repurposing and its efficacy in cancer therapy
Shubham Karpe, Manjula Kiran, S Majhi, et al.
Cancer Pathogenesis and Therapy (2025)
Open Access
PERSPECTIVES OF USING OF COMPOSITE NANO- AND MICROMATERIALS AS AGENTS FOR BIOMEDICAL APPLICATIONS
Stanislav Pshenichnikov, Anna V. Motorzhina, Anton A. Anikin, et al.
(2025), Iss. 1, pp. 127-139
Closed Access
Nanocarriers for the colonic diseases
Natalie Huchro, Yashwant Pathak
Elsevier eBooks (2025), pp. 71-82
Closed Access
Blocking Fusobacterium nucleatum-host cell interactions with responsive supramolecular GalNAc-derived nanoplatform for enhanced chemotherapy in colorectal cancer
T.-C. Wu, Danyang Jin, Mengdi Wu, et al.
Nano Today (2024) Vol. 56, pp. 102288-102288
Closed Access | Times Cited: 4
Genipin’s potential as an anti-cancer agent: from phytochemical origins to clinical prospects
Lapava Natallia, Aida Dama, Era Gorica, et al.
Medical Oncology (2024) Vol. 41, Iss. 8
Closed Access | Times Cited: 3
Investigating the therapeutic promise of Drug-Repurposed-Loaded Nanocarriers: A pioneering strategy in advancing colorectal cancer treatment
Amina Tarek Mneimneh, Nadine Darwiche, Mohammed M. Mehanna
International Journal of Pharmaceutics (2024) Vol. 664, pp. 124473-124473
Closed Access | Times Cited: 3
Revisiting nanomedicine design strategies for follow-on products: A model-informed approach to optimize performance
Shakti Nagpal, Thilagavathi Palaniappan, Jiong‐Wei Wang, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 1251-1270
Closed Access | Times Cited: 3
Unlocking the potential of titanium dioxide nanoparticles: an insight into green synthesis, optimizations, characterizations, and multifunctional applications
Ahmed Ghareeb, Amr Fouda, Rania Kishk, et al.
Microbial Cell Factories (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
QbD-Optimized, Phospholipid-Based Elastic Nanovesicles for the Effective Delivery of 6-Gingerol: A Promising Topical Option for Pain-Related Disorders
Mohammed Ghazwani, Mohammed H. Alqarni, Umme Hani, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 9983-9983
Open Access | Times Cited: 8
Current perspectives and trends in nanoparticle drug delivery systems in breast cancer: bibliometric analysis and review
Sheng Sun, Ye-hui Wang, Xiang Gao, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 7
Tumor therapy by targeting extracellular hydroxyapatite using novel drugs: A paradigm shift
Mohammed Noor Tantawy, J. Oliver McIntyre, Fiona E. Yull, et al.
Cancer Medicine (2024) Vol. 13, Iss. 3
Open Access | Times Cited: 2
Nanocarrier mediated entinostat and oxaliplatin combination therapy displayed enhanced efficacy against pancreatic cancer
Paras Mani Giri, Ashish Kumar, P Salu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116743-116743
Open Access | Times Cited: 2
"Unlocking Therapeutic Precision: “Camptotheca acuminata, a Traditional Chinese Herb Tailored for Phytonano-Cancer Theranostics”
Debojyoti Adak, Priyanka Ray, Saini Setua
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 11, pp. 100447-100447
Open Access | Times Cited: 2
Review of Prodrug and Nanodelivery Strategies to Improve the Treatment of Colorectal Cancer with Fluoropyrimidine Drugs
Santu Sarkar, Sezgin Kiren, William H. Gmeiner
Pharmaceutics (2024) Vol. 16, Iss. 6, pp. 734-734
Open Access | Times Cited: 2
Nanoparticles-Delivered Circular RNA Strategy as a Novel Antitumor Approach
Luisa Racca, Elisabetta Liuzzi, Simona Comparato, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8934-8934
Open Access | Times Cited: 2
Genetic-bioengineering of nanotechnology in cell-specific pharmaceutical targeting: Biological, pharmacological, and biochemical impact of nanomaterials-based breast cancer therapies
Javad Mohammadi, Sina Ebrahimi, Maryam Ghodousi, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106249-106249
Closed Access | Times Cited: 2
Nanomedicine for cancer patient‐centered care
Carlo Sorrentino, Stefania L. Ciummo, Cristiano Fieni, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access | Times Cited: 2
Piperlongumine: the amazing amide alkaloid from Piper in the treatment of breast cancer
Shatakshi Mitra, Protha Biswas, Anupriya Bandyopadhyay, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 5, pp. 2637-2650
Closed Access | Times Cited: 6
Advanced hybrid silica nanoparticles with pH-responsive diblock copolymer brushes: optimized design for controlled doxorubicin loading and release in cancer therapy
Shatha Lahmadi, Salman Alamery, Abeer M. Beagan, et al.
RSC Advances (2024) Vol. 14, Iss. 13, pp. 8819-8828
Open Access | Times Cited: 1
A Novel Algorithm for the Virtual Screening of Extensive Small Molecule Libraries Against ERCC1/XPF Protein-Protein Interaction for the Identification of Therapeutic Resistance-Bypassing Small Anticancer Molecules
Tuğba Gül Inci, Serap Acar, Dilek Turgut‐Balik
TURKISH JOURNAL OF BIOLOGY (2024) Vol. 48, Iss. 2, pp. 112-132
Open Access | Times Cited: 1
Targeted immunotherapy and nanomedicine for rhabdomyosarcoma: The way of the future
Victoria Judith Morel, Jochen Rößler, Michele Bernasconi
Medicinal Research Reviews (2024)
Open Access | Times Cited: 1
A Direct Comparison of Peptide Drug Delivery Systems Based on the Use of Hybrid Calcium Phosphate/Chitosan Nanoparticles versus Unmixed Calcium Phosphate or Chitosan Nanoparticles In Vitro and In Vivo
Е. В. Попова, Victoria Tikhomirova, О. В. Безнос, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15532-15532
Open Access | Times Cited: 3
Anti-cancer activity of zinc-tetraphenylporphyrin photosensitizer/dextran-graft-polyacrylamide copolymer/Au(Ag) nanoparticle nanohybrids
Oleg A. Yeshchenko, Nataliya Kutsevol, Pavlo Virych, et al.
RSC Advances (2024) Vol. 14, Iss. 8, pp. 5045-5054
Open Access
Analytical Techniques for Characterizing Tumor-Targeted Antibody-Functionalized Nanoparticles
Ana Camila Marques, Paulo Costa, Sérgia Velho, et al.
Life (2024) Vol. 14, Iss. 4, pp. 489-489
Open Access

Scroll to top